Prosecution Insights
Prosecution Insights
56 pending office actions • 37 clients • 54 examiners • 36 art units • 0 of 56 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 26 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 26 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §101 + other | 4 (7%) |
| §103 only | 17 (30%) |
| §102 only | 2 (4%) |
| §112 only | 3 (5%) |
| Double-patenting only | 2 (4%) |
| Double-patenting + other | 2 (4%) |
| Multi-statute (no §101) | 25 (45%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JOHNSON, KARA D | 2 | 69.3% | +24.4% |
| BASQUILL, SEAN M | 2 | 38.8% | +21.7% |
| ESPINOSA, CLAUDIA EDILMA | 1 | 52.9% | +56.1% |
| PUTTLITZ, KARL J | 1 | 69.1% | +18.6% |
| SINGH, ANOOP KUMAR | 1 | 42.7% | +67.3% |
| ING, MATTHEW W | 1 | 64.8% | +7.9% |
| KASAYAN, KATRIEL BARCELLANO | 1 | 50.0% | +0.0% |
| WEBB, WALTER E | 1 | 46.5% | +18.6% |
| LEE, JAE W | 1 | 65.6% | +39.0% |
| HAIDER, SYED | 1 | 83.5% | +8.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17182044 | GENE EXPRESSION-BASED BIOMARKER FOR THE DETECTION AND MONITORING OF BRONCHIAL PREMALIGNANT LESIONS | GROSS, CHRISTOPHER M | 53d overdue |
| 17778382 | ANTI-PD-L1/ANTI-B7-H3 MULTISPECIFIC ANTIBODIES AND USES THEREOF | NICKOL, GARY B | 23d overdue |
| 18931358 | OUTDOOR TABLETOP SYSTEM | ING, MATTHEW W | 15d overdue |
| 17782908 | INFLAMMATION-RESPONSIVE ANTI-INFLAMMATORY HYDROGELS | JONES, DAMERON LEVEST | 5d overdue |
| 18035358 | SYSTEMS FOR BUCCAL RELEASE OF PROTEINS | BROWE, DAVID | 3d overdue |
| 17786517 | METHODS AND COMPOSITIONS FOR CORRECTION OF DMD MUTATIONS | FOX, ALLISON M | 2d overdue |
| 18009731 | A CELLULAR MARKER OF COVID SEVERITY | QIAN, CELINE X | 28d |
| 17783573 | ALDH3A2 INHIBITION AND FERROPTOSIS INDUCTION FOR CANCER THERAPY | HUDSON, AMY ROSE | 29d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17383941 | METHODS AND DEVICES FOR REPAIR OF CRUSHED PERIPHERAL NERVE INJURIES WITH ERYTHROPOIETIN | BASQUILL, SEAN M | 24d overdue |
| 18508057 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | JOHNSON, KARA D | 30d |
| 18949619 | CELLS LACKING B2M SURFACE EXPRESSION AND METHODS FOR ALLOGENEIC ADMINISTRATION OF SUCH CELLS | SINGH, ANOOP KUMAR | 34d |
| 18020234 | A COMPOSITON COMPRISING MICROCAPSULES | BASQUILL, SEAN M | 49d |
| 19392118 | Untitled | ESPINOSA, CLAUDIA EDILMA | — |
| 19407141 | LIGAND-DRUG CONJUGATES | PUTTLITZ, KARL J | — |
| 18832837 | A METHOD OF FORMING A COMPOSITION COMPRISING A PROBIOTIC MICRO-ENCAPSULATED IN A DENATURED PLANT PROTEIN MATRIX | WEBB, WALTER E | — |
| 18773428 | METHODS OF EDITING DNA METHYLATION | LEE, JAE W | — |
| Art Unit | Apps |
|---|---|
| 1632 | 5 |
| 1612 | 3 |
| 1637 | 3 |
| 1684 | 2 |
| 1628 | 2 |
| 1631 | 2 |
| 1633 | 2 |
| 1614 | 2 |
| 1618 | 2 |
| 1646 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19392118 | Untitled | President and Fellows of Harvard College | ESPINOSA, CLAUDIA EDILMA | §101§102§103Other | Non-Final OA | — | Pending | ||
| 19407141 | LIGAND-DRUG CONJUGATES | Tripartite Therapeutics Inc. | PUTTLITZ, KARL J | 1646 | §102§112Other | Non-Final OA | — | Pending | Dec 03, 2025 |
| 18949619 | CELLS LACKING B2M SURFACE EXPRESSION AND METHODS FOR ALLOGENEIC ADMINISTRATION OF SUCH CELLS | President and Fellows of Harvard College | SINGH, ANOOP KUMAR | 1632 | §103§112 | Non-Final OA | 34d | Pending | Nov 15, 2024 |
| 18931358 | OUTDOOR TABLETOP SYSTEM | Agio International Company, Limited | ING, MATTHEW W | 3637 | §102§103§112 | Non-Final OA | 15d overdue | Pending | Oct 30, 2024 |
| 18845476 | INDUCED TOTIPOTENT POTENTIAL STEM CELLS, METHODS OF MAKING AND USING | Peking University | KASAYAN, KATRIEL BARCELLANO | §101§103§112 | Non-Final OA | — | Pending | Sep 10, 2024 | |
| 18832837 | A METHOD OF FORMING A COMPOSITION COMPRISING A PROBIOTIC MICRO-ENCAPSULATED IN A DENATURED PLANT PROTEIN MATRIX | Anabio Technologies Ltd. | WEBB, WALTER E | 1612 | §102§103 | Non-Final OA | — | Pending | Jul 24, 2024 |
| 18773428 | METHODS OF EDITING DNA METHYLATION | Whitehead Institute For Biomedical Research | LEE, JAE W | §103§112 | Non-Final OA | — | Pending | Jul 15, 2024 | |
| 18742930 | SC-BETA CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME | President and Fellows of Harvard College | JOHNSON, KARA D | §103 | Non-Final OA | — | Pending | Jun 13, 2024 | |
| 18742623 | METHOD OF CELL-CLUSTER ANALYSIS | Chang Gung Memorial Hospital, Linkou | HAIDER, SYED | 2633 | §101 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18642665 | SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION | President and Fellows of Harvard College | SHIAO, REI TSANG | DP | Non-Final OA | — | Pending | Apr 22, 2024 | |
| 18701596 | OPTIMIZED BIOSYNTHESIS PATHWAY FOR CANNABINOID BIOSYNTHESIS | Cellibre, Inc. | LOUNTOS, GEORGE THEMISTOCLIS | 1652 | §102§103§112 | Non-Final OA | 84d | Pending | Apr 15, 2024 |
| 18611871 | METHOD FOR TREATING ZIKA VIRUS INFECTION WITH QUERCETIN-CONTAINING COMPOSITIONS | Quercis Pharma AG | CRAIGO, BAHAR ALAWI | 1699 | DP | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18587488 | THERMALLY PROTECTIVE COMPOSITE MATERIAL | Bemis Associates, Inc. | HANDVILLE, BRIAN | 1783 | §102§103§112 | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18576073 | METHODS | Genetix Biotherapeutics Inc. | TSUI, YUNG-SHENG M | 1684 | §103 | Non-Final OA | — | Pending | Jan 02, 2024 |
| 18391648 | METHOD FOR IMPROVING DIABETIC WOUND HEALING USING MIR-200B | Hungkuang University | SAPKOTA, SURAJ | 4100 | §103 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18571123 | NOVEL COMPOUNDS FOR THE TREATMENT AND PREVENTION OF NEUROLOGICAL COMPLICATIONS OF VIRAL INFECTIONS | Sunregen Healthcare AG | MI, QIUWEN | 1655 | §102 | Final Rejection | 46d | Pending | Dec 15, 2023 |
| 18533542 | THIN-SHELL POLYMERIC NANOPARTICLES AND USES THEREOF | Academia Sinica | PHAN, DOAN THI-THUC | 1613 | §103 | Final Rejection | 23d overdue | Pending | Dec 08, 2023 |
| 18517497 | BRIARANE COMPOUNDS AND THEIR USE | National Museum Of Marine Biology And Aquarium | SHI, GENBIN | 1628 | §102§103§112 | Non-Final OA | — | Pending | Nov 22, 2023 |
| 18561712 | TREATMENT OF ANTIPHOSPHOLIPID SYNDROME USING S-HYDROXYCHLOROQUINE | Genovate Biotechnology Co. Ltd. | VAJDA, KRISTIN ANN | 1622 | §103 | Non-Final OA | 9d | Pending | Nov 16, 2023 |
| 18560883 | ENGINEERED CELLS, ENZYMES, AND METHODS FOR PRODUCING CANNABINOIDS | Cellibre, Inc. | GORDON, MELENIE LEE | 1651 | §102§103§112 | Non-Final OA | 84d | Pending | Nov 14, 2023 |
| 18508057 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | The Children's Hospital of Philadelphia | JOHNSON, KARA D | 1632 | §103§112 | Non-Final OA | 30d | Pending | Nov 13, 2023 |
| 18386551 | CHROMOSOME NEIGHBORHOOD STRUCTURES AND METHODS RELATING THERETO | Whitehead Institute For Biomedical Research | GROOMS, TIFFANY NICOLE | 1637 | §102§103§112 | Non-Final OA | — | Pending | Nov 02, 2023 |
| 18495731 | METHODS AND COMPOSITIONS FOR IN VIVO DIRECT GENOME EDITING IN PLANTS | The Regents of the University of California | KUMAR, VINOD | 1663 | §103 | Final Rejection | 96d overdue | Pending | Oct 26, 2023 |
| 18286405 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | The Children's Hospital of Philadelphia | MARTIN, PAUL C | 1653 | §102§103§112 | Non-Final OA | 61d | Pending | Oct 11, 2023 |
| 18285494 | CHEMICAL REPROGRAMMING OF HUMAN SOMATIC CELLS INTO PLURIPOTENT CELLS | Peking University | MIANO, JOSEPH PAUL | 1631 | §103§112DP | Non-Final OA | — | Pending | Oct 03, 2023 |
| 18372855 | LIFTING YOKE | Danhydra A/S | VU, STEPHEN A | §112 | Non-Final OA | — | Pending | Sep 26, 2023 | |
| 18231009 | METHOD FOR IMMUNE CELL TRACKING | Megapro Biomedical Co., Ltd. | LEWOCZKO, EVAN MICHAEL | 1612 | §103DPOther | Non-Final OA | 70d | Pending | Aug 07, 2023 |
| 18209360 | POLYPHARMACEUTICAL DRUG COMPOSITIONS AND RELATED METHODS | Aveta Biomics, Inc. | PURDY, KYLE A | 1611 | §103 | Final Rejection | 63d | Pending | Jun 13, 2023 |
| 18205841 | LIGAND-POLAR DRUG CONJUGATES | Tripartite Therapeutics Inc. | HERNANDEZ, JACKSON J | 1674 | §102§103§112 | Non-Final OA | — | Pending | Jun 05, 2023 |
| 18038943 | MODULATING TRANSCRIPTIONAL CONDENSATES | Whitehead Institute For Biomedical Research | BUCHANAN, BAILEY CHEYENNE | 1682 | §102§103§112 | Non-Final OA | — | Pending | May 25, 2023 |
| 18035683 | METHODS | Genetix Biotherapeutics Inc. | WESTON, ALYSSA G | 1633 | §102 | Final Rejection | 62d | Pending | May 05, 2023 |
| 18035358 | SYSTEMS FOR BUCCAL RELEASE OF PROTEINS | UNIVERSITE CLAUDE BERNARD - LYON 1 | BROWE, DAVID | 1617 | §103§112 | Final Rejection | 3d overdue | Pending | May 04, 2023 |
| 18034876 | USE OF BRAIN ORGANOIDS AND SINGLE CELL GENOMICS TO UNDERSTAND AND TREAT NEURODEVELOPMENTAL AND NEUROPSYCHIATRIC DISORDERS | Massachusetts Institute Of Technology | KAPUSHOC, STEPHEN THOMAS | 1683 | §103§112 | Non-Final OA | — | Pending | May 01, 2023 |
| 18021156 | EX VIVO BRAIN TUMOR MODEL | Massachusetts Institute Of Technology | REGLAS, GILLIAN CHELSEA | 1632 | §102§103§112 | Non-Final OA | — | Pending | Feb 13, 2023 |
| 18020234 | A COMPOSITON COMPRISING MICROCAPSULES | Teagasc -The Agriculture And Food Development Authority | BASQUILL, SEAN M | 1614 | §103Other | Final Rejection | 49d | Pending | Feb 07, 2023 |
| 18019954 | A PHARMACEUTICAL COMPOSITION IN ORAL DOSAGE FORM | Teagasc-The Agriculture And Food Development Authority | TRAN, SUSAN T | 1615 | §103 | Final Rejection | — | Pending | Feb 06, 2023 |
| 18009731 | A CELLULAR MARKER OF COVID SEVERITY | Sorbonne Universite | QIAN, CELINE X | 1637 | §101§102§103§112 | Non-Final OA | 28d | Pending | Dec 11, 2022 |
| 17920260 | ELAFIBRANOR FOR THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS | Genfit | LEE, ANDREW P | 1691 | §103 | Non-Final OA | 71d overdue | Pending | Oct 20, 2022 |
| 17917365 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | Tiba Biotech LLC | VIGIL, TORIANA NICHOLE | 1612 | §103 | Non-Final OA | — | Pending | Oct 06, 2022 |
| 17945709 | METHOD OF BIOMARKER DETECTION IN COMPANION ANIMALS | Uni Pharma Co., LTD. | HUANG, MICKEY NMN | 1758 | §103 | Non-Final OA | 20d | Pending | Sep 15, 2022 |
| 17894333 | METHODS OF TREATING CDGSH IRON SULFUR DOMAIN 2 INSUFFICIENCY-ASSOCIATED DISORDERS | Chang Gung Medical Foundation, Chang Gung Memorial Hospital, Linkou | COPPINS, JANET L | 1628 | §112 | Non-Final OA | 7d | Pending | Aug 24, 2022 |
| 17878774 | CDC20 VARIANTS RESISTANT TO ANTI-MITOTIC DRUGS AND RELATED METHODS AND COMPOSITIONS | Whitehead Institute For Biomedical Research | YOUTCHOM PENDIE, EMMANUEL LED | 1647 | §102§103 | Non-Final OA | — | Pending | Aug 01, 2022 |
| 17786517 | METHODS AND COMPOSITIONS FOR CORRECTION OF DMD MUTATIONS | President and Fellows of Harvard College | FOX, ALLISON M | 1633 | §103§112 | Non-Final OA | 2d overdue | Pending | Jun 16, 2022 |
| 17783573 | ALDH3A2 INHIBITION AND FERROPTOSIS INDUCTION FOR CANCER THERAPY | Shrikanta Chattopadhyay | HUDSON, AMY ROSE | 1636 | §103§112 | Final Rejection | 29d | Pending | Jun 08, 2022 |
| 17782908 | INFLAMMATION-RESPONSIVE ANTI-INFLAMMATORY HYDROGELS | Nanyang Technological University | JONES, DAMERON LEVEST | 1618 | §102§103§112 | Non-Final OA | 5d overdue | Pending | Jun 06, 2022 |
| 17778382 | ANTI-PD-L1/ANTI-B7-H3 MULTISPECIFIC ANTIBODIES AND USES THEREOF | I-Mab | NICKOL, GARY B | 1643 | §102§103§112Other | Non-Final OA | 23d overdue | Pending | May 19, 2022 |
| 17728927 | THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS | The Children's Hospital of Philadelphia | WILSON, MICHAEL C | 1638 | §103§112 | Final Rejection | — | Pending | Apr 25, 2022 |
| 17763441 | NANOPARTICLE COMPOSITIONS FOR GENE THERAPY | UNIVERSITY COLLEGE DUBLIN | LIPPOLIS, ALEXANDRA ROSE | 1637 | §103 | Non-Final OA | — | Pending | Mar 24, 2022 |
| 17588038 | IN VIVO GUIDE RNA LIBRARIES AND METHODS OF MAKING THE SAME | Whitehead Institute For Biomedical Research | DHAR, MATASHA | 1632 | §103 | Non-Final OA | — | Pending | Jan 28, 2022 |
| 17540968 | MODIFIED T CELLS AND METHODS OF MAKING AND USING THE SAME | President and Fellows of Harvard College | WEHBE, ANNE MARIE SABRINA | 1634 | §112 | Non-Final OA | — | Pending | Dec 02, 2021 |
| 17615579 | REPRODUCIBLE BRAIN ORGANOIDS AND METHODS OF MAKING | The Broad Institute, Inc. | BEHARRY, ZANNA MARIA | 1632 | §103§112 | Final Rejection | — | Pending | Nov 30, 2021 |
| 17613004 | ENDOCRINE DIFFERENTIATION-INDUCING MOLECULE | President and Fellows of Harvard College | GONZALES, JOSEPHINE MARIA | 1631 | §101§102§103§112 | Non-Final OA | — | Pending | Nov 19, 2021 |
| 17611560 | METHODS OF CHARACTERIZING AND UTILIZING AGENT-CONDENSATE INTERACTIONS | Whitehead Institute For Biomedical Research | PERREIRA, MELISSA JEAN | 1618 | §103 | Non-Final OA | — | Pending | Nov 15, 2021 |
| 17608463 | PEPTIDE DERIVATIVES AND CONJUGATES THEREOF FOR TREATING CANCER | The University of Sydney | REYNOLDS, FRED H | 1658 | §103 | Non-Final OA | 85d overdue | Pending | Nov 02, 2021 |
| 17383941 | METHODS AND DEVICES FOR REPAIR OF CRUSHED PERIPHERAL NERVE INJURIES WITH ERYTHROPOIETIN | Shu-Tung And Alice Li Foundation Inc. | BASQUILL, SEAN M | 1614 | §103 | Final Rejection | 24d overdue | Pending | Jul 23, 2021 |
| 17182044 | GENE EXPRESSION-BASED BIOMARKER FOR THE DETECTION AND MONITORING OF BRONCHIAL PREMALIGNANT LESIONS | Trustees Of Boston University | GROSS, CHRISTOPHER M | 1684 | §102§103 | Final Rejection | 53d overdue | Pending | Feb 22, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial